THERAPEUTICSMD, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$38M
↓-3.0% -$1Mvs FY2024
Total Liabilities
$11M
↓-5.9% -$672Kvs FY2024
Equity
$27M
↓-1.8% -$494Kvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $38M | $39M |
| Current Assets | $14M | $12M |
| Cash | $0 | $5M |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other Current | $14M | $7M |
| Non-Current Assets | $23M | $27M |
| PPE | $0 | $0 |
| Goodwill | $0 | $0 |
| Intangibles | $4M | $4M |
| Investments | $0 | $0 |
| Other Non-Current | $19M | $22M |
| Total Liab+Eq | $38M | $39M |
| Current Liab. | $5M | $5M |
| Accounts Payable | $377K | $258K |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $4M | $5M |
| Non-Current Liab. | $6M | $6M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $6M | $6M |
| Equity | $27M | $27M |
| Retained Earnings | $952M | $952M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · TXMD · Comparing FY2025 vs FY2024